Meeting ReportsDiagnostics Development

Collaborations Among Academia, Government, and Industry in the Diagnostics Space: Barriers and Some Ideas for Solutions

See allHide authors and affiliations

Science Translational Medicine  22 Dec 2010:
Vol. 2, Issue 63, pp. 63mr3
DOI: 10.1126/scitranslmed.3001633

You are currently viewing the abstract.

View Full Text

Abstract

The development and commercialization of diagnostic assays is distinct from that of therapeutic drugs in many important respects; for example, there are more variable regulatory requirements and reduced outside investments for diagnostics. The diagnostics industry has a pro-collaborative stance, because there is considerable mutual benefit in working in partnership with university or government researchers. However, there are substantial barriers to industry-academic collaborations. A Clinical and Translational Science Awards Industry Forum titled “Promoting Efficient and Effective Collaborations Among Academia, Government, and Industry” was held in February 2010, and a session at this forum was organized to list some of the most important barriers to diagnostics development and to discuss some possible solutions.

Footnotes

  • Citation: G. Evans, F. Austin, Collaborations Among Academia, Government, and Industry in the Diagnostics Space: Barriers and Some Ideas for Solutions. Sci. Transl. Med. 2, 63mr3 (2010).

View Full Text